Sartorius Stedim Biotech

Health Care Equipment
DIM.PA
€ 303 0.36
Share price
$ 29 bn
Market Cap
$ 31 bn
Enterprise Value

Carbon footprint

1.1 Ton
GHG emissions per $ 1 mln investment
0.04x the weighted average for S&P 500
FY2020
How is this calculated?
-5.6%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-4.2%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Sartorius Stedim Biotech aims to reduce Scope 1 + 2 by 45% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
Sartorius Stedim Biotech's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Sartorius Stedim Biotech's GHG emissions (location-based) (Kt of CO2e)

Sartorius Stedim Biotech's carbon footprint

Sartorius Stedim Biotech reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 35 Kt (-2.1 /-5.6% y-o-y).

No public disclosure of Scope 3 emissions has been found for Sartorius Stedim Biotech at the moment.

The company is committed to reducing Scope 1 + 2 by 45% by 2030 from a base year 2019, which translates into the estimated reduction of -1.5 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...